Literature DB >> 16490067

Morbidity and mortality of infants born at the threshold of viability: ten years' experience in a single neonatal intensive care unit, 1991-2000.

Shigeharu Hosono1, Tsutomu Ohno, Hirofumi Kimoto, Masaki Shimizu, Kensuke Harada.   

Abstract

BACKGROUND: The purpose of the present paper was to evaluate the mortality and morbidity of infants born at 22-24 weeks gestation.
METHODS: A total of 78 infants born at 22-24 weeks gestation, who were admitted between January 1991 through December 2000, were retrospectively studied.
RESULTS: Seventy-one of 78 infants were enrolled in the present study. One year survival rates at 22, 23 and 24 weeks were 40.0% (2/5), 61.1% (11/18), and 50.0% (24/48), respectively. Failure of response to surfactant and air leak were associated with death in infants born at 23 weeks gestation. Low Apgar score, intraventricular hemorrhage (> or =III), and sepsis were correlated with death in infants born at 24 weeks gestation. The handicap rates of survivors born at 22, 23, and 24 weeks gestation were 100, 36.4, and 26.1%, respectively.
CONCLUSIONS: The present study indicates that infants born at 22 weeks gestation, in whom pulmonary structure is established, that is, a viable lung that can exchange gas with exogenous surfactant, have a chance to survive, but neurological outcome is still poor. Every possible effort should be made to extend gestation beyond 22 weeks.

Entities:  

Mesh:

Year:  2006        PMID: 16490067     DOI: 10.1111/j.1442-200X.2006.02154.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  The effects of umbilical cord milking in extremely preterm infants: a randomized controlled trial.

Authors:  M I March; M R Hacker; A W Parson; A M Modest; M de Veciana
Journal:  J Perinatol       Date:  2013-07-18       Impact factor: 2.521

Review 2.  Factors influencing the care provided for periviable babies in Australia: a narrative review.

Authors:  Susan Ireland; Robin Ray; Sarah Larkins; Lynn Woodward
Journal:  Reprod Health       Date:  2015-11-25       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.